Ophthalmology

 

FREE BLOG Major topics and trends discussed at HBI 2024

HBI’s annual conference took place last week. Almost 600 attendees — comprising CXOs of healthcare providers, investors, suppliers and advisors — travelled from 40 different countries to London for the event. Over the course of three days of roundtables, workshops and panel discussions, they explored the big issues the sector faces, and the opportunities available to the private sector in helping to solve them.

Healthcare investment “through the bottom of the cycle” — Goldberg (Rothschild)

At last year’s conference Hedley Goldberg, Managing Director at multinational investment bank Rothschild, predicted healthcare M&A activity would begin picking up again in Q4 2023 or Q1 2024. But we’re now halfway through 2024 and there are still very few deals above €500m taking place. Goldberg is confident, however, that we have now passed through the bottom of the cycle.

HBI 2024 Day Three, Morning Briefing

The morning of day three of HBI 2024 included sessions on the right model for AI, ophthalmology, diagnostic imaging, nuclear medicine and occupational health.

HBI 2024 Day One Briefing

HBI 2024 opened with a day of workshops, concluding with the HBI 2024 welcome reception hosted by medtech company Siemens Healthineers, and a dinner hosted by consulting firm McKinsey & Company.

Interview: Dr. Volker Wendel, Sanoptis

Dr. Volker Wendel founded Sanoptis in 2018 in Switzerland with Carsten Horn. Six years later, the group has grown to more than 400 locations across six European countries. The group was initially backed by PE firm Telemos Capital, who then sold it to Belgian holding company Group Bruxelles Lambert (in 2022). Wendel explains to us how the group is able to add value to ophthalmologists who join the network and shares which areas the group will be focusing on in the coming years.

UK ophtha market heating up, whilst Germany’s remains cool

The UK’s for-profit ophthalmology sector is heating up, with multiple groups likely to come up for sale this year. This is being driven by the long term increase in the amount of cataract surgeries the NHS is outsourcing. Meanwhile deal activity in Germany’s sector is still on pause, due to a decrease in cataract surgery post Covid.

Top 5 European ophthalmology players

This infographic showcases Europe's top 5 ophthalmology players by revenue in the reporting period 2018–2022: Veonet Group, Sanoptis, Artemis Augenkliniken, Clinica Baviera, and Optegra.

Find Us